Daiichi Sankyo Co. Ltd.

Pharmaceuticals
Japan
Earnings Per Share Growth (%)-73.91%
Cost of Goods Sold (US$ Millions)$2,647
Current Liabilities (US$ Millions)$3,154
Total Assets (US$ Millions)$9,348
Long Term Debt$1,504
Return on Equity6.31%
Revenue (US$ Millions)$8,194
Total Company Assets$15,788
Revenue Growth (%)7.30%
Net Income (US$ Millions)$684
Earnings Per Share (US$)($73.91)
Total Equity (US$ Millions)$10,229
Profit Margin (%)8.34%
Debt To Equity Ratio (%)0.15%
Inventory Turnover$1,198